WC
ACAD icon

Weatherbie Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Weatherbie Capital’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$16.6M Buy
576,784
+409,034
+244% +$10.8M 2.09% 19
2016
Q3 		$5.34M Sell
167,750
-233,892
-58% -$7.93M 0.67% 43
2016
Q2 		$13M Sell
401,642
-228,292
-36% -$7.64M 1.85% 22
2016
Q1 		$17.6M Buy
629,934
+90,305
+17% +$1.97M 2.32% 18
2015
Q4 		$19.2M Buy
539,629
+39,675
+8% +$1.4M 2.26% 19
2015
Q3 		$16.5M Buy
499,954
+47,286
+10% +$1.97M 1.92% 22
2015
Q2 		$19M Sell
452,668
-248,188
-35% -$9.61M 1.93% 23
2015
Q1 		$22.8M Buy
700,856
+230,051
+49% +$7.91M 2.25% 21
2014
Q4 		$14.9M Sell
470,805
-114,243
-20% -$3.24M 1.39% 32
2014
Q3 		$14.5M Buy
+585,048
New +$13.7M 1.36% 32

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Weatherbie Capital's ACAD Position: Q4 2016 in Review

Weatherbie Capital increased its Acadia Pharmaceuticals (ACAD) stake by 244% in Q4 2016, buying an estimated $10.8M and bringing the position to 576,784 shares worth $16.6M. The position accounts for 2.09% of the portfolio, ranked #19.

Weatherbie Capital first reported a position in ACAD in Q3 2014 and has held it in 10 quarters since. The position peaked at $22.8M in Q1 2015. 225 funds tracked by Wall St. Rank hold ACAD as of Q4 2016.

  • Weatherbie Capital held 576,784 shares of Acadia Pharmaceuticals worth $16.6M as of Q4 2016.
  • Weatherbie Capital bought 409,034 Acadia Pharmaceuticals shares in Q4 2016, an estimated $10.8M.
  • Acadia Pharmaceuticals made up 2.09% of Weatherbie Capital's portfolio in Q4 2016, its #19 holding.
  • Weatherbie Capital first reported a position in Acadia Pharmaceuticals in Q3 2014 and has held it in 10 quarters since.
  • Weatherbie Capital's Acadia Pharmaceuticals position peaked at $22.8M in Q1 2015.
  • 225 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2016.

Based on Weatherbie Capital's 13F filing for Q4 2016, filed 14 Feb 2017.